Analyst Ratings for [DHR] Danaher Corporation

2/3/25	Downgrades	Outperform Mkt Perform	X
DHR Danaher Raymond James
12/23/24	Initiated	Sector Perform	X
DHR Danaher Scotiabank
12/19/24	Initiated	Buy	X
DHR Danaher Guggenheim
$275
12/13/24	Upgrades	Neutral Buy	X
DHR Danaher BofA Securities
$290
10/31/24	Upgrades	Peer Perform Outperform	X
DHR Danaher Wolfe Research
$285
10/1/24	Initiated	Overweight	X
DHR Danaher Stephens
$315
8/28/24	Initiated	Equal Weight	X
DHR Danaher Wells Fargo
$280
6/3/24	Resumed	Buy	X
DHR Danaher Jefferies
$295
4/17/24	Upgrades	Hold Buy	X
DHR Danaher HSBC Securities
$280
1/24/24	Downgrades	Overweight Eq Weight	X
DHR Danaher Barclays
$240
12/18/23	Initiated	Hold	X
DHR Danaher HSBC Securities
12/13/23	Resumed	Peer Perform	X
DHR Danaher Wolfe Research
12/7/23	Downgrades	Buy Neutral	X
DHR Danaher Goldman
$215 $205
7/19/23	Initiated	Outperform	X
DHR Danaher Raymond James
$270
5/1/23	Initiated	Outperform	X
DHR Danaher SVB Securities
$300
4/26/23	Downgrades	Buy Neutral	X
DHR Danaher BofA Securities
$310 $250
4/18/23	Upgrades	Eq Weight Overweight	X
DHR Danaher Wells Fargo
$275 $285
1/5/23	Downgrades	Outperform Neutral	X
DHR Danaher Credit Suisse
$315 $300
12/14/22	Initiated	Buy	X
DHR Danaher Deutsche Bank
$310
10/24/22	Downgrades	Buy Hold	X
DHR Danaher The Benchmark Company
$325
8/25/22	Initiated	Outperform	X
DHR Danaher Credit Suisse
$340
8/17/22	Resumed	Outperform	X
DHR Danaher Bernstein
$330 $340
7/20/22	Initiated	Buy	X
DHR Danaher UBS
$297
6/1/22	Upgrades	Sec Perform Outperform	X
DHR Danaher RBC Capital Mkts
$299 $310
4/25/22	Downgrades	Overweight Eq Weight	X
DHR Danaher Wells Fargo
$265
1/11/22	Initiated	Outperform	X
DHR Danaher Bernstein
$365
10/15/21	Resumed	Outperform	X
DHR Danaher Cowen
$350
7/16/21	Initiated	Buy	X
DHR Danaher The Benchmark Company
$330
4/7/21	Resumed	Outperform	X
DHR Danaher Robert W. Baird
$249
3/3/21	Resumed	Overweight	X
DHR Danaher Barclays
$260
7/19/19	Reiterated	Buy	X
DHR Danaher Needham
$142 $155
6/11/19	Initiated	Neutral	X
DHR Danaher Piper Jaffray
5/30/19	Initiated	Outperform	X
DHR Danaher Wolfe Research
4/17/19	Reiterated	Buy	X
DHR Danaher Needham
$138 $141
2/28/19	Reiterated	Buy	X
DHR Danaher Needham
$114 $138
2/25/19	Upgrades	Neutral Buy	X
DHR Danaher Janney
1/3/19	Initiated	Buy	X
DHR Danaher Needham
$114
4/20/18	Reiterated	Buy	X
DHR Danaher Stifel
$108 $114
2/15/18	Initiated	Overweight	X
DHR Danaher Barclays
$110

DHR Danaher Corporation

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. As of December 31, 2016, Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.